Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2020) Vol. 47, Iss. 13, pp. 3033-3046
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Peptide–drug conjugate-based novel molecular drug delivery system in cancer
Yishen Zhu, Kexing Tang, Jiayi Lv
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 10, pp. 857-869
Closed Access | Times Cited: 107
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
Romain Eychenne, Christelle Bouvry, Mickaël Bourgeois, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 4012-4012
Open Access | Times Cited: 98
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms
Emilia Fortunati, Giulia Argalia, Lucia Zanoni, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 5, pp. 703-720
Open Access | Times Cited: 46
18F-AlF-NOTA-Octreotide Outperforms68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 632-638
Open Access | Times Cited: 45
Self‐Assembled Peptide‐Based Nanodrugs: Molecular Design, Synthesis, Functionalization, and Targeted Tumor Bioimaging and Biotherapy
Xin Luan, Hao Kong, Peng He, et al.
Small (2022) Vol. 19, Iss. 3
Closed Access | Times Cited: 41
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling
Mariacristina Failla, Giuseppe Floresta, Vincenzo Abbate
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 4, pp. 592-623
Open Access | Times Cited: 24
18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use
Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 6, pp. 835-841
Open Access | Times Cited: 23
The aluminium-[18F]fluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules
Stephen J. Archibald, Louis Allott
EJNMMI Radiopharmacy and Chemistry (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 51
FAPI-04 PET/CT Using [18F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient
Xiao Jiang, Xiaoxiong Wang, Taipeng Shen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 43
Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
Juan Sun, Zhenyuan Huangfu, Jiangtao Yang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114538-114538
Closed Access | Times Cited: 34
Radiochemistry with {Al18F}2+: Current status and optimization perspectives for efficient radiofluorination by complexation
Sébastien Schmitt, Emmanuel Moreau
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215028-215028
Open Access | Times Cited: 19
Head-to-Head Comparison of68Ga-NODAGA-JR11 and68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study
Zefang Lin, Wenjia Zhu, Jiaying Zhang, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1406-1411
Open Access | Times Cited: 17
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
Niloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 129-129
Open Access | Times Cited: 36
Synthesis, preclinical evaluation, and a pilot clinical imaging study of [18F]AlF-NOTA-JR11 for neuroendocrine neoplasms compared with [68Ga]Ga-DOTA-TATE
Qing Xie, Teli Liu, Jing Ding, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 10, pp. 3129-3140
Closed Access | Times Cited: 33
[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study
Atia Samim, Thomas Blom, Alex J. Poot, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1146-1157
Open Access | Times Cited: 28
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
Valentina Ambrosini, Lucia Zanoni, Angelina Filice, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1055-1055
Open Access | Times Cited: 27
Molecular imaging Theranostics of Neuroendocrine Tumors
Emilia Fortunati, Norma Bonazzi, Lucia Zanoni, et al.
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 4, pp. 539-554
Closed Access | Times Cited: 16
Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
Kushal Chakraborty, Jagannath Mondal, Jeong Man An, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 971-971
Open Access | Times Cited: 16
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
Diletta Calabrò, Giulia Argalia, Valentina Ambrosini
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1059-1059
Open Access | Times Cited: 39
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours
Leonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 11, pp. 3571-3581
Open Access | Times Cited: 28
Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
Marcus Unterrainer, Sophie Carina Kunte, Lena M. Unterrainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3390-3399
Open Access | Times Cited: 13
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
Lennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, et al.
EJNMMI Research (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
Leandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3483-3483
Open Access | Times Cited: 11
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial
Meixi Liu, Chao Ren, Haiqiong Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3719-3730
Closed Access | Times Cited: 4
Carcinoid Heart Disease: A Classic One, But Not Always Remembered
Pamela Ramírez-Rangel, Jorge D Rodríguez-Esparza, Xochitl A. Ortiz‐León, et al.
Cureus (2025)
Open Access
Page 1 - Next Page

Scroll to top